» Articles » PMID: 33385119

Mapping Germ-layer Specification Preventing Genes in HPSCs Via Genome-scale CRISPR Screening

Overview
Journal iScience
Publisher Cell Press
Date 2021 Jan 1
PMID 33385119
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the biological processes that determine the entry of three germ layers of human pluripotent stem cells (hPSCs) is a central question in developmental and stem cell biology. Here, we genetically engineered hPSCs with the germ layer reporter and inducible CRISPR/Cas9 knockout system, and a genome-scale screening was performed to define pathways restricting germ layer specification. Genes clustered in the key biological processes, including embryonic development, mRNA processing, metabolism, and epigenetic regulation, were centered in the governance of pluripotency and lineage development. Other than typical pluripotent transcription factors and signaling molecules, loss of function of mesendodermal specifiers resulted in advanced neuroectodermal differentiation, given their inter-germ layer antagonizing effect. Regarding the epigenetic superfamily, microRNAs enriched in hPSCs showed clear germ layer-targeting specificity. The cholesterol synthesis pathway maintained hPSCs via retardation of neuroectoderm specification. Thus, in this study, we identified a full landscape of genetic wiring and biological processes that control hPSC self-renewal and trilineage specification.

Citing Articles

Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.

Cotta G, Teixeira Dos Santos R, Costa G, Lacerda S Int J Mol Sci. 2024; 25(20).

PMID: 39456792 PMC: 11507014. DOI: 10.3390/ijms252011009.


CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant.

Kaplan S, Wong W, Yan J, Pulecio J, Cho H, Li Q Cell Rep. 2024; 43(8):114640.

PMID: 39163202 PMC: 11406439. DOI: 10.1016/j.celrep.2024.114640.


Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity.

Chen Y, Zhou Y, Zhou Z, Fang Y, Ma L, Zhang X Stem Cell Res Ther. 2023; 14(1):11.

PMID: 36691086 PMC: 9872349. DOI: 10.1186/s13287-022-03233-z.


H NMR Metabolite Monitoring during the Differentiation of Human Induced Pluripotent Stem Cells Provides New Insights into the Molecular Events That Regulate Embryonic Chondrogenesis.

Coope A, Ghanameh Z, Kingston O, Sheridan C, Barrett-Jolley R, Phelan M Int J Mol Sci. 2022; 23(16).

PMID: 36012540 PMC: 9409419. DOI: 10.3390/ijms23169266.


Protocol for genome-scale CRISPR screening in engineered lineage reporter hPSCs to study cell fate determination.

Zhou Z, Ma L, Zhang X STAR Protoc. 2021; 2(2):100548.

PMID: 34095862 PMC: 8164093. DOI: 10.1016/j.xpro.2021.100548.

References
1.
Folmes C, Nelson T, Martinez-Fernandez A, Arrell D, Lindor J, Dzeja P . Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011; 14(2):264-71. PMC: 3156138. DOI: 10.1016/j.cmet.2011.06.011. View

2.
Gifford C, Ziller M, Gu H, Trapnell C, Donaghey J, Tsankov A . Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell. 2013; 153(5):1149-63. PMC: 3709577. DOI: 10.1016/j.cell.2013.04.037. View

3.
Mair B, Tomic J, Masud S, Tonge P, Weiss A, Usaj M . Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Rep. 2019; 27(2):599-615.e12. DOI: 10.1016/j.celrep.2019.02.041. View

4.
Wang L, Chen Y . Signaling Control of Differentiation of Embryonic Stem Cells toward Mesendoderm. J Mol Biol. 2015; 428(7):1409-22. DOI: 10.1016/j.jmb.2015.06.013. View

5.
Shu J, Zhang K, Zhang M, Yao A, Shao S, Du F . GATA family members as inducers for cellular reprogramming to pluripotency. Cell Res. 2015; 25(2):169-80. PMC: 4650575. DOI: 10.1038/cr.2015.6. View